You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LYEL Award Disclosure
Aguirre Jarrad Mattieu · SEC Form 4 · Filed Sep 10, 2026
Award
Calculated transaction value
$0
Aguirre Jarrad Mattieu Chief Medical Officer
LYEL
Lyell Immunopharma
LYEL
Transaction date
Sep 10, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed same day
LYEL daily price context
Close on/before transaction
$12.2
Sep 10, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Option (right to buy) on Common Stock
- Quantity / price
- 47,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002150331-26-000002
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Award | Sep 10, 2026 | $0 |